Good questions.
Clear answers.

Compounded semaglutide is a prescription medicine that a state-licensed US 503A compounding pharmacy prepares for an individual patient. It is not FDA-approved and is not an approved generic of a branded medicine. The FDA does not review compounded preparations for safety, effectiveness or quality before they are sold. Ask your clinician why an approved medicine cannot meet your medical needs before you choose one.

Semaglutide acts on one hormone receptor, GLP-1; tirzepatide acts on two, GIP and GLP-1. Both are weekly injections when prescribed. In a direct comparison of the manufacturers’ medicines, tirzepatide produced greater average weight loss at the studied doses; that trial did not study compounded preparations. At REMEVi, tirzepatide costs more than semaglutide on every plan. Your medical history and how well you tolerate each medicine also guide the choice.

No one can promise a timeline or an amount. Response varies with the medicine, the dose and how quickly it is increased, your health history and your follow-up. The STEP-1 and SURMOUNT-1 trials of brand-name medicines measured average results over 68 and 72 weeks; those averages are not predictions for a compounded preparation or for you. Your clinician reviews your progress and adjusts the plan at follow-up.

The plan price includes the prescribed medication if a clinician approves it, the clinician evaluation and follow-up, supplies, shipping and bilingual care coordination. Lab tests required by your clinician for the GLP-1 program are included in your plan price. There is no separate membership fee, and the price does not increase when your prescribed dose does. The month-to-month plan is billed every four weeks; the 12-week and 24-week plans are paid upfront.

REMEVi does not bill insurance; the published program prices are self-pay. HSA and FSA cards are accepted as payment methods, but whether a purchase qualifies for reimbursement depends on your plan and its administrator. Confirm eligibility and the documentation your administrator requires before you assume a purchase will be reimbursed. Insurance-covered brand-name programs are a separate option to discuss with your own doctor or insurer.

Yes. You can cancel future renewals without a cancellation fee. Prepaid terms are paid in advance; refund eligibility is governed by the Cancellation & Refund Policy. The month-to-month plan renews every four weeks until you cancel, and the 12-week and 24-week plans are paid upfront for the full term, with the total shown before you choose.

Read the Cancellation & Refund Policy →

Start with the free health questionnaire; no card is needed to start. A licensed clinician reviews your history and decides whether treatment is appropriate, and may ask for more information, labs or a live visit. You see the full charge before you authorize payment, and starting does not guarantee a prescription. You can compare treatments and payment terms on the pricing page first.

REMEVi’s GLP-1 program is available in 49 states and Washington, DC — every state except Louisiana. Your provider must be licensed in the state where you receive care. Care happens online, so there is no clinic to visit. If you travel or move, tell the care team before your next visit or shipment.

See the state-by-state list →

No. You do not need an existing prescription or an in-person visit to request an evaluation. Care begins online; the clinician decides whether they can treat you safely remotely and whether a live visit, labs or in-person care is needed. Share existing prescriptions and recent lab results if you have them, because they help the clinician review your history.

Yes. The intake questionnaire, the clinical evaluation, dosing instructions, the patient portal, billing, and our care coordinators and support are all available in Spanish. You choose English or Spanish when you start, and you can switch languages at any time. If you need a particular arrangement for a clinical visit, tell the team when it is scheduled.

Yes, with your permission. You can ask a trusted person to help you understand the process, and you tell the team whom you authorize to take part. Your medical information and consent remain yours: a family member should not answer medical questions or authorize treatment without your involvement. Because care is available in Spanish, a relative does not have to interpret for you.

Clinicians in the OpenLoop clinical network prescribe, and the clinician caring for you must be licensed in the state where you receive care. REMEVi’s named team member, Linda West-Conforti, RN, reviews patient-education materials; she does not prescribe or make treatment decisions. Our medical-team page explains both roles and shows how to verify a license with your state board before your first prescription.

Compounded medicines are regulated under federal law and by state boards of pharmacy, with separate frameworks for 503A pharmacies, which prepare a prescription for an individual patient, and 503B outsourcing facilities. REMEVi’s partner pharmacies are state-licensed 503A pharmacies. A pharmacy license, registration or inspection does not mean a medicine is FDA-approved. Our pharmacy page links to official verification tools; ask which pharmacy will fill your prescription.

Is compounded GLP-1 legal in 2026? →

Yes. REMEVi is LegitScript-certified (ID 50384507), and you can check the public listing through the verification link on our medical-team page. Platform certification is different from approval of a drug: it does not establish the safety or effectiveness of a compounded preparation. It means the business was reviewed against LegitScript’s certification standards for healthcare merchants.

Follow the missed-dose instructions for your specific prescription or ask your clinician or dispensing pharmacy. Instructions differ between semaglutide, tirzepatide and oral preparations, and they can depend on how long ago the dose was due. Do not double a dose or use another product’s instructions to decide what to take. If you have missed several doses, ask before restarting.

Median 3.6 days from payment to shipment (1.9–7.0 days for the middle half of orders; 33 orders, July–September 2026). Your timing can differ. That time covers the clinician’s review and the pharmacy’s preparation; carrier delivery comes after shipment. Approval is not automatic, and it can take longer if the clinician needs more information, a visit or labs. The team can help you check your order status.

Yes. Shipping is included in the listed GLP-1 plan price, with no separate shipping charge. Medication is supplied in four-week cycles. Follow the dispensing pharmacy’s storage and handling instructions for your exact preparation, because requirements can differ by product, and contact the pharmacy and the care team if a package arrives warm or damaged.

Yes, with planning. Ask the pharmacy about temperature limits and storage for your exact preparation before you travel. Keep medication in its labeled packaging, pack enough supplies, and check your airline and destination rules. Tell the care team if the trip changes where you will receive clinical care, because your clinician must be licensed where you are.

Contact REMEVi right away with your order details and, if relevant, photos of the package. Do not use medication that may be damaged or stored outside its temperature limits until the dispensing pharmacy confirms what to do. Replacement and refund decisions depend on the circumstances and follow the published policy. The care team can coordinate with the pharmacy for you.